Stephanie Suzanne de O. Scott
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Stephanie Suzanne de O. Scott has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
Claudia Carvalho Mendes Schiavon
Hospital Universitário Walter Cantídio, Universidade Federal do Ceará, Av Rogaciano Leite 900 apto 503, Torre Friburgo, Guararapes, Fortaleza, Ceará, Brazil
1 shared publicationFrancisco de Assis Aquino Gondim
Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
1 shared publication- Licia Pacheco Luna
Department of Radiology, Division of Neuroradiology, Johns Hopkins Medical Center, Baltimore, MD, USA
1 shared publication Manoel Alves Sobreira-Neto
Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
1 shared publicationPaulo Ribeiro Nóbrega
Hospital Universitário Walter Cantídio, Universidade Federal do Ceará, Av Rogaciano Leite 900 apto 503, Torre Friburgo, Guararapes, Fortaleza, Ceará, Brazil
1 shared publicationPedro Braga-Neto
Department of Clinical Medicine, Universidade Federal do Ceará, Fortaleza, Ceará, Brazil
1 shared publication
Latest Publications
- 2 June 2017
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 23 (4) , 625-631
Immunoglobulin-responsive chikungunya encephalitis: two case reports
Chikungunya virus is an alphavirus transmitted by the mosquito Aedes, mainly Aedes aegypti and Aedes albopictus, that can cause acute illness, mostly self-limited, characterized by fever, maculopapular rash, and disabling polyarthritis/arthralgia, with an incubation period of 1 to 12 days. Chikungunya was largely regarded as a non-fatal and self-limited disease, but recently, serious cases have been reported including some with severe involvement of the nervous system, such as meningoencephalitis, myelitis, polyradiculitis, and polyradiculoneuropathy. In this report, we describe the clinical and laboratory findings of two patients with encephalitis associated with chikungunya in a northeastern city in Brazil, who exhibited a good outcome, with improvement after treatment with i.v. immunoglobulin (IVIg).
- 2 June 2017
- Published by Springer Nature in Journal of NeuroVirology
- Vol. 23 (4) , 625-631
Immunoglobulin-responsive chikungunya encephalitis: two case reports
Chikungunya virus is an alphavirus transmitted by the mosquito Aedes, mainly Aedes aegypti and Aedes albopictus, that can cause acute illness, mostly self-limited, characterized by fever, maculopapular rash, and disabling polyarthritis/arthralgia, with an incubation period of 1 to 12 days. Chikungunya was largely regarded as a non-fatal and self-limited disease, but recently, serious cases have been reported including some with severe involvement of the nervous system, such as meningoencephalitis, myelitis, polyradiculitis, and polyradiculoneuropathy. In this report, we describe the clinical and laboratory findings of two patients with encephalitis associated with chikungunya in a northeastern city in Brazil, who exhibited a good outcome, with improvement after treatment with i.v. immunoglobulin (IVIg).